Cargando…
Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
BACKGROUND: Roles of cancer stem cells and early growth response gene 1 (Egr1) in carcinogenesis have been extensively studied in lung cancer. However, the role of Egr1 in the metastasis of lung cancer remains undetermined, especially in regard to stem cell-related pathways. METHODS: Egr1, osteopont...
Autores principales: | Feng, Yin-Hsun, Su, Yu-Chu, Lin, Shuo-Fu, Lin, Pey-Ru, Wu, Chao-Liang, Tung, Chao-Ling, Li, Chien-Feng, Shieh, Gia-Shing, Shiau, Ai-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688208/ https://www.ncbi.nlm.nih.gov/pubmed/31399076 http://dx.doi.org/10.1186/s12885-019-6014-5 |
Ejemplares similares
-
The Pro-Survival Oct4/Stat1/Mcl-1 Axis Is Associated with Poor Prognosis in Lung Adenocarcinoma Patients
por: Su, Yu-Chu, et al.
Publicado: (2021) -
Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer
por: Lu, Chia-Sing, et al.
Publicado: (2020) -
Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity
por: Su, Bing-Hua, et al.
Publicado: (2015) -
Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer
por: Hu, Che-Yuan, et al.
Publicado: (2023) -
Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer
por: Lu, Chia-Sing, et al.
Publicado: (2016)